What is WashingtonSQDerm?
Based in the heart of Greenwich Village, WashingtonSQDerm operates as a high-end clinical practice under the leadership of Dr. Samer Jaber. The organization distinguishes itself through a dual-focus model that integrates essential medical dermatology—such as skin cancer screenings and acne management—with advanced cosmetic procedures including laser therapy, Botox, and dermal fillers. The clinic is recognized for its commitment to evidence-based medicine, blending scientific rigor with a patient-centric philosophy that prioritizes individualized treatment plans. This comprehensive service portfolio positions the company as a leader in the regional healthcare landscape, catering to a discerning clientele that demands both clinical excellence and aesthetic precision.
How much funding has WashingtonSQDerm raised?
WashingtonSQDerm has raised a total of $347K across 2 funding rounds:
Debt
$150K
Debt
$197K
Debt (2020): $150K with participation from PPP
Debt (2021): $197K led by PPP
Key Investors in WashingtonSQDerm
PPP
Public-Private Partnership
What's next for WashingtonSQDerm?
With the infusion of $197K, WashingtonSQDerm is well-positioned to scale its operational infrastructure and potentially broaden its service offerings. The late-stage nature of this financing suggests a strategic pivot toward optimizing patient throughput and investing in cutting-edge laser technology to maintain a competitive edge. As the practice continues to navigate the intersection of medical necessity and elective cosmetic enhancement, the focus will likely remain on sustaining high-quality care standards while exploring opportunities for facility modernization or service line diversification. This capital deployment serves as a critical catalyst for long-term sustainability in the evolving dermatology sector.
See full WashingtonSQDerm company page
